Preparatory Work to Assess Adherence to Oral Chemotherapy

Completed

Conditions studied: Chronic Myeloid Leukemia

In brief

This study to find out more about how patients take their anticancer medications and challenges related to taking cancer medications.

Key facts

Study ID

NCT02895542

Run by

Wake Forest University Health Sciences

People needed

86

Starts

2016-12-20

Expected to finish

2017-04-28

Last updated by the study team

2018-06-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient is diagnosed with Chronic Myeloid Leukemia (CML) and is receiving care for CML at a participating CCDR NCORP practice,
• Patient had been prescribed one of the following oral anticancer agents for CML for ≥30 days (Imatinib, Nilotinib, Dasatinib, Bosutinib, Ponatinib). Prior use of any of these medications is allowed, as long as they have been on a stable regimen for at least 30 days prior to enrollment.
• Patient is 18 years of age or older

You may not qualify if…

• Patient does not speak English or requires an interpreter for medical visits
• Patient is cognitively impaired, as determined by the referring provider

Where it is running

• Wake Forest School of Medicine — Winston-Salem, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.